Loading the company…
Loading the company…
Families: Bone graft & orthobiologics, Lumbar fusion.
All companies · Product and company coverage
In the last ten years FDA made 1 decision for Lifenet Health (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2024 (1). The latest was on 2024-11-21.
| Family | Decisions on record |
|---|---|
| Bone graft & orthobiologics | 1 |
| Lumbar fusion | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2024-11-21 | 510(k) | K242799 | PliaFX Flo |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Lifenet Health.
In 2025, Lifenet Health reported engagement with 1,651 surgeons and other clinicians in the states MedaRep covers, worth $579K in consulting, speaking, meals and travel for its device products, the most in Virginia ($145K to 176). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Virginia ($145K, 176 engaged), Maryland ($84K, 41 engaged), New York ($76K, 186 engaged), Florida ($52K, 80 engaged), Massachusetts ($39K, 34 engaged).